What question did this study set out to answer?

The aim is to compare survival outcomes and treatment patterns between stage III inflammatory and non-inflammatory breast cancer.

April 11, 2026Open Access

Survival and Treatment Patterns in Stage III Inflammatory and Noninflammatory Breast Cancer

Key Points

The aim is to compare survival outcomes and treatment patterns between stage III inflammatory and non-inflammatory breast cancer.
Cohort study design focusing on stage III breast cancer patients.
Comparison of breast cancer-specific survival (BCSS) and overall survival (OS) between inflammatory and non-inflammatory subtypes.
Analysis of treatment modalities over time, particularly focusing on treatment in inflammatory breast cancer.
Inflammatory breast cancer (IBC) showed worse BCSS and OS compared to non-IBC across all tumor subtypes.
Usage of treatment modalities in IBC was low and declined significantly over time.
BCSS and OS did not improve over time for IBC patients, while they improved for non-IBC patients.

Abstract

In this cohort study of stage III BC, IBC was associated with worse BCSS and OS than stage III non-IBC across all tumor subtypes. TMT use in IBC was low and decreased significantly over time. BCSS and OS did not improve over time for patients with IBC treated with TMT, whereas BCSS and OS improved for those with non-IBC.

Survival and Treatment Patterns in Stage III Inflammatory and Noninflammatory Breast Cancer

Key Points

Abstract

Cite This Study

Also Consider

Also Consider